منابع مشابه
Determination of Dosimetric Characteristics of IrSeed 125I Brachytherapy Source
Introduction Low dose rate brachytherapy sources have been widely used for interstitial implants in tumor sites, particularly in prostate. Dosimetric characteristics of a new IrSeed 125I brachytherapy source have been determined using the LiF thermoluminescent dosimeter (TLD) chips. Materials and Methods Dose rate constant, radial dose function, and anisotropy function around the IrSeed 125I so...
متن کاملDosimetry Comparison of Water Phantom and Complete Eye Definition for 125I and 103Pd Brachytherapy Plaques
Introduction: In this paper, by complete definition of human eye containing the various parts and their materials, the difference between this model and a homogeneous water phantom are compared for two ophthalmic plaques using 125I and 103Pd. Material and methods: The simulation of the two phantoms were performed in the MCNP-4C code and by using the geometry of a three-dimensional eye, differen...
متن کاملCT-guided 125I brachytherapy for recurrent ovarian cancer
This retrospective study was to evaluate the local control and survival of 125I brachytherapy for recurrent ovarian cancer. 52 125I brachytherapy procedures were performed in 47 patients with 51 recurrent ovarian cancer lesions. The follow-up period was 1-55 months (median 12 months). The local control rate (LC) of 3, 6, 12, 24 and 36 months was 93.3%, 77.7%, 58.9%, 38.7% and 19.3%, respectivel...
متن کاملCT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma
Purpose: The study evaluated the feasibility, clinical effectiveness, and quality of life of computed tomography (CT)-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma (NPC). Methods: We recruited 81 patients diagnosed with locally recurrent NPC after previous radiotherapy with or without chemotherapy. Thirty-nine patients received 125I brachytherapy (group A) and 42 rece...
متن کامل125I brachytherapy for localized prostate cancer: a single institution experience.
AIMS AND BACKGROUND To evaluate the clinical outcome of a cohort of localized prostate cancer patients treated with 125I permanent brachytherapy at the University of Turin. METHODS AND STUDY DESIGN A retrospective analysis was carried out on 167 consecutive patients with early stage prostate adenocarcinoma who underwent 125I brachytherapy between January 2003 and December 2010. A minimum foll...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Progress in Nuclear Science and Technology
سال: 2014
ISSN: 2185-4823
DOI: 10.15669/pnst.4.888